Sign in

CIK 0001133416

  • Non-accelerated filer
  • Smaller reporting company

GALECTIN THERAPEUTICS INC

Sign in to watch
Ticker
GALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
043562325
Phone
+1 678-620-3186
Business address
4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
Former names
PRO PHARMACEUTICALS INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-06-15 LEWIS JOEL President and CEO Grant or award +13,196 $1.46 $19K 897,362
2023-05-31 LEWIS JOEL President and CEO Grant or award +12,272 $1.57 $19K 884,166
2023-05-15 LEWIS JOEL President and CEO Grant or award +11,748 $1.64 $19K 871,894
2023-04-28 LEWIS JOEL President and CEO Grant or award +10,947 $1.76 $19K 860,146
2023-04-14 LEWIS JOEL President and CEO Grant or award +9,585 $2.01 $19K 849,199
2023-03-31 LEWIS JOEL President and CEO Grant or award +9,175 $2.10 $19K 839,614
2023-03-15 LEWIS JOEL President and CEO Grant or award +10,140 $1.90 $19K 830,439
2023-03-01 LEWIS JOEL President and CEO Shares withheld for taxes −75,529 $2.07 $156K 820,299
2023-02-28 LEWIS JOEL President and CEO Grant or award +9,308 $2.07 $19K 895,828
2023-02-21 ELDRED KARY Director Purchase +1,000 $1.59 $2K 47,215
2023-02-16 LEWIS JOEL President and CEO Purchase +1,000 $1.52 $2K 1,000
2023-02-15 LEWIS JOEL President and CEO Grant or award +13,380 $1.44 $19K 886,520
2023-02-07 LEWIS JOEL President and CEO Grant or award +143,836 $1.43 $206K 873,140
2023-01-31 LEWIS JOEL President and CEO Grant or award +15,086 $1.16 $17K 729,304
2023-01-26 Zordani Richard A. Jr. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-01-26 Shlevin Harold H. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-01-26 Schwartz Elissa J. Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-01-26 Rubin Marc Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-01-26 OMENN GILBERT S Director Grant or award · Stock Option (right to buy) +40,000 40,000
2023-01-26 FREEMAN KEVIN D Director Grant or award · Stock Option (right to buy) +40,000 40,000

Page 17 of 21 · 404 trades